DVA vs UHS
DaVita Inc. and Universal Health Services Inc., side by side — 10 fiscal years reported in USD, drawn from SEC filings.
Most recent reported year
| Metric | DVA | UHS |
|---|---|---|
| Revenue | $13.6B | $17.4B |
| Net income | $746.8M | $1.5B |
| Gross margin | · | · |
| Net margin | 7.9% | 8.7% |
| Return on equity | · | 21.4% |
| Diluted EPS | $9.84 | $23.10 |
| Dividend / share | · | $0.80 |
| Payout ratio | 0.0% | 3.4% |
| Free cash flow | $1.3B | $849.2M |
| Equity | $-651.1M | $7.3B |
| Net debt / equity | · | 0.63× |
| Current ratio | 1.29× | 1.05× |
| Revenue CAGR 5y | 3.4% | 8.5% |
| Profit CAGR 5y | −0.7% | 9.5% |
UHS bills 1.3× the revenue of DVA, and keeps more of each dollar of revenue as profit (8.7% against 7.9%).
The stronger figure of the pair is set in bold. That is arithmetic, not a recommendation — this page does not pick a winner. "·" marks a figure not available in our data.
10 years side by side
| Fiscal year | DVA | UHS |
|---|---|---|
| FY2025 | $13.6B | $17.4B |
| FY2024 | $12.8B | $15.8B |
| FY2023 | $12.1B | $14.3B |
| FY2022 | $11.6B | $13.4B |
| FY2021 | $11.6B | $12.6B |
| FY2020 | $11.6B | $11.6B |
| FY2019 | $11.4B | $11.4B |
| FY2018 | $11.4B | $10.8B |
| FY2017 | $10.9B | $10.4B |
| FY2016 | $10.7B | $9.8B |
Bottom line
| Fiscal year | DVA | UHS |
|---|---|---|
| FY2025 | $746.8M | $1.5B |
| FY2024 | $936.3M | $1.1B |
| FY2023 | $691.5M | $717.8M |
| FY2022 | $560.4M | $675.6M |
| FY2021 | $978.5M | $991.6M |
| FY2020 | $773.6M | $944.0M |
| FY2019 | $811.0M | $814.9M |
| FY2018 | $159.4M | $779.7M |
| FY2017 | $663.6M | $752.3M |
| FY2016 | $879.9M | $702.4M |
16 fiscal years
| Fiscal year | Difference | Ahead |
|---|---|---|
| FY2025 | −$3,721,760,000 | UHS |
| FY2024 | −$3,012,385,000 | UHS |
| FY2023 | −$2,141,829,000 | UHS |
| FY2022 | −$1,789,476,000 | UHS |
| FY2021 | −$1,023,320,000 | UHS |
| FY2020 | −$8,293,000 | UHS |
| FY2019 | +$10,220,000 | DVA |
| FY2018 | +$632,573,000 | DVA |
| FY2017 | +$466,769,000 | DVA |
| FY2016 | +$941,257,000 | DVA |
| FY2015 | +$938,794,000 | DVA |
| FY2014 | +$4,590,018,000 | DVA |
| FY2013 | +$4,396,177,000 | DVA |
| FY2012 | +$1,224,880,000 | DVA |
| FY2011 | −$28,416,000 | UHS |
| FY2010 | +$1,319,463,000 | DVA |
The higher-revenue side has changed between DVA and UHS over this period. The gap has widened since the earliest year compared.
16 of 18 comparable fiscal years — a year missing data on either side is not counted.
16 fiscal years
| Fiscal year | Difference | Ahead |
|---|---|---|
| FY2025 | −0.8 pp | UHS |
| FY2024 | +2.4 pp | DVA |
| FY2023 | +2.8 pp | DVA |
| FY2022 | +1.8 pp | DVA |
| FY2021 | +2.6 pp | DVA |
| FY2020 | +0.4 pp | DVA |
| FY2019 | +1.7 pp | DVA |
| FY2018 | −4.5 pp | UHS |
| FY2017 | +0.2 pp | DVA |
| FY2016 | +2.0 pp | DVA |
| FY2015 | −4.0 pp | UHS |
| FY2014 | −0.6 pp | UHS |
| FY2013 | −1.1 pp | UHS |
| FY2012 | +0.8 pp | DVA |
| FY2011 | +1.9 pp | DVA |
| FY2010 | +2.2 pp | DVA |
The higher net margin has changed hands between DVA and UHS over this period.
16 of 18 comparable fiscal years — a year missing data on either side is not counted.
Standard deviation, each side
DVA's net margin has been more volatile than UHS's over the 16 comparable fiscal years — 1.9 percentage points of standard deviation against 1.1.
16 of 18 comparable fiscal years — a year missing data on either side is not counted.
Year by year
The lead in net margin changed hands between DVA and UHS over these 16 fiscal years — DVA led in 11 and UHS in 5.
16 of 18 comparable fiscal years — a year missing data on either side is not counted.
Standard deviation, each side
DVA's return on equity has been more volatile than UHS's over the 17 comparable fiscal years — 39.5 percentage points of standard deviation against 2.1.
17 of 18 comparable fiscal years — a year missing data on either side is not counted.
Year by year
The lead in return on equity changed hands between DVA and UHS over these 17 fiscal years — DVA led in 12 and UHS in 5.
17 of 18 comparable fiscal years — a year missing data on either side is not counted.